WHO drops two trial arms for COVID-19 treatment

The World Health Organization has discontinued the Solidarity Trial’s hydroxychloroquine and lopinavir/ritonavir arms as interim results show little or no benefit WHO has accepted the trial’s International Steering Committee recommendation to discontinue the two trial arms, based on evidence from interim results for hydroxychloroquine vs standard of care and for lopinavir/ritonavir vs standard of care,